The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of DENTSPLY Sirona Inc (NASDAQ: XRAY) was $19.31 for the day, down -0.77% from the previous closing price of $19.46. In other words, the price has decreased by -$0.77 from its previous closing price. On the day, 1.82 million shares were traded. XRAY stock price reached its highest trading level at $19.735 during the session, while it also had its lowest trading level at $19.22.
Ratios:
Our analysis of XRAY’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.52. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 1.25. In the meantime, Its Debt-to-Equity ratio is 0.93 whereas as Long-Term Debt/Eq ratio is at 0.76.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 04, 2024, initiated with a Neutral rating and assigned the stock a target price of $21.
Needham reiterated its Buy rating for the stock on October 25, 2024, while the target price for the stock was revised from $34 to $29.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 18 ’24 when LUCIER GREGORY T bought 5,000 shares for $18.37 per share. The transaction valued at 91,850 led to the insider holds 71,730 shares of the business.
LUCIER GREGORY T bought 1,000 shares of XRAY for $18,279 on Nov 15 ’24. The Director now owns 16,000 shares after completing the transaction at $18.28 per share. On Nov 12 ’24, another insider, Campion Simon D, who serves as the President, CEO & Member of BOD of the company, bought 11,306 shares for $17.72 each. As a result, the insider paid 200,341 and bolstered with 272,247 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XRAY now has a Market Capitalization of 3868256256 and an Enterprise Value of 5877433344. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.98 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 1.507 whereas that against EBITDA is 9.747.
Stock Price History:
Over the past 52 weeks, XRAY has reached a high of $37.60, while it has fallen to a 52-week low of $17.21. The 50-Day Moving Average of the stock is -12.86%, while the 200-Day Moving Average is calculated to be -27.60%.
Shares Statistics:
XRAY traded an average of 3.06M shares per day over the past three months and 2322430 shares per day over the past ten days. A total of 198.80M shares are outstanding, with a floating share count of 197.58M. Insiders hold about 0.60% of the company’s shares, while institutions hold 107.00% stake in the company. Shares short for XRAY as of 1731628800 were 9891811 with a Short Ratio of 3.24, compared to 1728950400 on 16350203. Therefore, it implies a Short% of Shares Outstanding of 9891811 and a Short% of Float of 5.72.
Dividends & Splits
With its trailing 12-month dividend rate of 0.62, XRAY has a forward annual dividend rate of 0.62. Against a Trailing Annual Dividend Yield of 0.03186023The stock’s 5-year Average Dividend Yield is 1.27.
